Grant: CIHR Fellowship
Direct Payment
$137,500.00
Signal-dependent regulators of LXR activity for the treatment of atherosclerosis
FY 2010-11
Summary
Cardiovascular disease is the leading cause of death in the Western world and therefore represents a significant health care concern and a major burden on resources for Canadians. For atherosclerosis, plaque formation in arterial walls occurs as an inflammatory response to high cholesterol, with mature plaques at significant risk for rupture, which not only releases destructive inflammatory mediators into the circulatory system, but can also occlude major arteries resulting in heart attack or stroke. Prior attempts to treat atherosclerosis by preventing cholesterol accumulation in these immune cells, namely macrophages, have produced potentially lethal side effects due to the nature of the protein specifically targeted by these drugs. However, by defining additional regulatory mechanisms responsible for preventing cholesterol accumulation, new therapeutic targets could be identified. We therefore propose to identify and characterize the molecular regulatory mechanisms controlling cholesterol removal from macrophages. This will provide important insights into the pathways involved in cholesterol regulation and lesion development, and will allow for the design of therapeutics for the treatment and prevention of atherosclerosis in humans.
Department
Program
CIHR Fellowship
Recipient
Location
Washington, United States of America
Type
Grant
Source
CIHR Funding Decisions Database
As published
Id
214258
Name
Gillespie Mark A
Region
Washington
Country
United States of America
Orgtype
Research Institution
Instname2
Circulatory and Respiratory Health
Theme2
Biomedical
Prcname2
Fellowships - Post-PhD
Projecttitle
Signal-dependent regulators of LXR activity for the treatment of atherosclerosis
Programtype2
Fellowship Programs
Orgnameinp2
Direct Payment
Cihramount2
$137,500
Cihrequipment2
$0
Programname2
CIHR Fellowship
Keyworddelim
Atherosclerosis; Cardiovascular Disease; Co-Regulatory Factor; Inflammation; Macrophage Gene Regulation; Nuclear Receptor; Quantitative Mass Spectrometry; Reverse Cholesterol Transport; Srm Targeted Mass Spectrometry; Transcriptional Regulation
Abstract
Cardiovascular disease is the leading cause of death in the Western world and therefore represents a significant health care concern and a major burden on resources for Canadians. For atherosclerosis, plaque formation in arterial walls occurs as an inflammatory response to high cholesterol, with mature plaques at significant risk for rupture, which not only releases destructive inflammatory mediators into the circulatory system, but can also occlude major arteries resulting in heart attack or stroke. Prior attempts to treat atherosclerosis by preventing cholesterol accumulation in these immune cells, namely macrophages, have produced potentially lethal side effects due to the nature of the protein specifically targeted by these drugs. However, by defining additional regulatory mechanisms responsible for preventing cholesterol accumulation, new therapeutic targets could be identified. We therefore propose to identify and characterize the molecular regulatory mechanisms controlling cholesterol removal from macrophages. This will provide important insights into the pathways involved in cholesterol regulation and lesion development, and will allow for the design of therapeutics for the treatment and prevention of atherosclerosis in humans.
Competitiondate
201010
Approvedterm2
2 yrs 9 mths
Pinamesdelim
Gillespie, Mark A
Approvedterm
2 ans 9 mois
Cihrcontribution2
~ $137,500~ $0~